Rashmi Chugh

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Topics

Histone Deacetylase

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Andrew J Wagner, Vinod Ravi, Richard F Riedel, Kristen Ganjoo, Brian Andrew Van Tine, Rashmi Chugh, Lee D Cranmer, Erlinda M Gordon, Jason L Hornick, Heng Du, Li Ding, Anita N Schmid, Willis H Navarro, David J Kwiatkowski, Mark A Dickson
Phase II Trial of nab- Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Andrew J Wagner, Vinod Ravi, Richard F Riedel, Kristen Ganjoo, Brian Andrew Van Tine, Rashmi Chugh, Lee D Cranmer, Erlinda M Gordon, Jason L Hornick, Heng Du, Li Ding, Anita N Schmid, Willis H Navarro, David J Kwiatkowski, Mark A Dickson
Phase II Trial of nab- Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Andrew J Wagner, Vinod Ravi, Richard F Riedel, Kristen Ganjoo, Brian Andrew Van Tine, Rashmi Chugh, Lee D Cranmer, Erlinda M Gordon, Jason L Hornick, Heng Du, Li Ding, Anita N Schmid, Willis H Navarro, David J Kwiatkowski, Mark A Dickson
Phase II Trial of nab- Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Andrew J Wagner, Vinod Ravi, Richard F Riedel, Kristen Ganjoo, Brian Andrew Van Tine, Rashmi Chugh, Lee D Cranmer, Erlinda M Gordon, Jason L Hornick, Heng Du, Li Ding, Anita N Schmid, Willis H Navarro, David J Kwiatkowski, Mark A Dickson
Phase II Trial of nab- Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Andrew J Wagner, Vinod Ravi, Richard F Riedel, Kristen Ganjoo, Brian Andrew Van Tine, Rashmi Chugh, Lee D Cranmer, Erlinda M Gordon, Jason L Hornick, Heng Du, Li Ding, Anita N Schmid, Willis H Navarro, David J Kwiatkowski, Mark A Dickson
Phase II Trial of nab- Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Andrew J Wagner, Vinod Ravi, Richard F Riedel, Kristen Ganjoo, Brian Andrew Van Tine, Rashmi Chugh, Lee D Cranmer, Erlinda M Gordon, Jason L Hornick, Heng Du, Li Ding, Anita N Schmid, Willis H Navarro, David J Kwiatkowski, Mark A Dickson
Phase II Trial of nab- Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Riha Vaidya, Joseph M Unger, Stephen Caldwell, Jessica P Hwang, Rashmi Chugh, Monica A Tincopa, Kathryn B Arnold, Dawn L Hershman, Scott D Ramsey
Universal Viral Screening of Newly Diagnosed Cancer Patients in the United States: A Cost Efficiency Evaluation. Cancer research communications (2023)
Srivandana Akshintala, Nicole C Mallory, Yao Lu, Karla V Ballman, Scott M Schuetze, Rashmi Chugh, Robert G Maki, Denise K Reinke, Brigitte C Widemann, Ae Rang Kim
Outcome of Patients With Malignant Peripheral Nerve Sheath Tumors Enrolled on Sarcoma Alliance for Research Through Collaboration (SARC) Phase II Trials. The oncologist (2023)
H Catherine Wilbur, Dan R Robinson, Yi-Mi Wu, Chandan Kumar-Sinha, Arul M Chinnaiyan, Rashmi Chugh
Identification of Novel PGR-NR4A3 Fusion in Extraskeletal Myxoid Chondrosarcoma and Resultant Patient Benefit From Tamoxifen Therapy. JCO precision oncology 6 (2022)
Cindy Y Jiang, Lili Zhao, Scott M Schuetze, Rashmi Chugh
Giant Cell Tumor of Bone: Effect of Longer Dosing Intervals of Denosumab on Tumor Control and Bone-related Complications. The oncologist 27 (7) (2022)
Andrew J Wagner, Vinod Ravi, Richard F Riedel, Kristen Ganjoo, Brian Andrew Van Tine, Rashmi Chugh, Lee Cranmer, Erlinda M Gordon, Jason L Hornick, Heng Du, Berta Grigorian, Anita N Schmid, Shihe Hou, Katherine Harris, David J Kwiatkowski, Neil P Desai, Mark A Dickson
nab-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (33) (2021)
Sylvia Adams, Megan Othus, Sandip Pravin Patel, Kathy D Miller, Rashmi Chugh, Scott M Schuetze, Mary D Chamberlin, Barbara J Haley, Anna Maria V Storniolo, Mridula P Reddy, Scott A Anderson, Collin T Zimmerman, Anne P O'Dea, Hamid R Mirshahidi, Jordi Rodon Ahnert, Frank J Brescia, Olwen Hahn, Jane M Raymond, David D Biggs, Roisin M Connolly, Elad Sharon, Larissa A Korde, Robert C Gray, Edward Mayerson, Melissa Plets, Charles D Blanke, Young Kwang Chae, Razelle Kurzrock
A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609). Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Brigitte C Widemann, Yao Lu, Denise Reinke, Scott H Okuno, Christian F Meyer, Gregory M Cote, Rashmi Chugh, Mohammed M Milhem, Angela C Hirbe, Ae Rang Kim, Brian Turpin, Joseph G Pressey, Eva Dombi, Nalini Jayaprakash, Lee J Helman, Ndidi Onwudiwe, Karen Cichowski, John P Perentesis
Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016). Sarcoma 2019 (2019)
Edwin Choy, Karla Ballman, James Chen, Mark A Dickson, Rashmi Chugh, Suzanne George, Scott H Okuno, Raphael Pollock, Rajiv M Patel, Antje Hoering, Shreyaskumar R Patel
Corrigendum to "SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy". Sarcoma 2019 (2019)
Brittany L Siontis, Lili Zhao, Monika Leja, Jonathan B McHugh, Maryann M Shango, Laurence H Baker, Scott M Schuetze, Rashmi Chugh
Primary Cardiac Sarcoma: A Rare, Aggressive Malignancy with a High Propensity for Brain Metastases. Sarcoma 2019 (2019)
Edwin Choy, Karla Ballman, James Chen, Mark A Dickson, Rashmi Chugh, Suzanne George, Scott H Okuno, Raphael Pollock, Rajiv M Patel, Antje Hoering, Shreyaskumar R Patel
SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy. Sarcoma 2018 (2018)